...
search icon
qntm-img

Quantum BioPharma Ltd. Share Price

QNTM
NAQ
$3.65
-$0.2
(-5.19%)
1D
Industry: Biotechnology Sector: Health Care

Quantum BioPharma Ltd. Analyst Forecast

Quantum BioPharma Ltd. Share Price Chart

Quantum BioPharma Ltd. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$14.80M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
43.61K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.81
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.75 L
$38.25 H
$3.65

About Quantum BioPharma Ltd., Common Stock

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada. more

Industry: BiotechnologySector: Health Care

Quantum BioPharma Ltd. Stock Returns

Time FrameQNTMSectorS&P500
1-Week Return-6.12%0.91%2.13%
1-Month Return-47.13%-0.72%-0.47%
3-Month Return-55.82%2.24%1.29%
6-Month Return-84.87%19.1%7.71%
1-Year Return-68.03%7.15%14.7%
3-Year Return-96.59%16.96%67.75%
5-Year Return-98%33.23%76.25%
10-Year Return-99.67%142.74%271.83%

Quantum BioPharma Ltd. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue----490.57K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit----(490.57K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-49057100,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses30.69M33.74M27.43M23.79M16.14M[{"date":"2020-12-31","value":90.95,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.29,"profit":true},{"date":"2023-12-31","value":70.5,"profit":true},{"date":"2024-12-31","value":47.82,"profit":true}]
Operating Income(30.69M)(33.74M)(27.43M)(23.79M)(16.14M)[{"date":"2020-12-31","value":-3069108800,"profit":false},{"date":"2021-12-31","value":-3374366000,"profit":false},{"date":"2022-12-31","value":-2742961100,"profit":false},{"date":"2023-12-31","value":-2378949800,"profit":false},{"date":"2024-12-31","value":-1613626000,"profit":false}]
Total Non-Operating Income/Expense2.01M(262.41K)1.04M6.34M1.75M[{"date":"2020-12-31","value":31.63,"profit":true},{"date":"2021-12-31","value":-4.14,"profit":false},{"date":"2022-12-31","value":16.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":27.52,"profit":true}]
Pre-Tax Income(28.45M)(33.94M)(26.70M)(18.23M)(14.92M)[{"date":"2020-12-31","value":-2845223200,"profit":false},{"date":"2021-12-31","value":-3393795600,"profit":false},{"date":"2022-12-31","value":-2670366200,"profit":false},{"date":"2023-12-31","value":-1823058800,"profit":false},{"date":"2024-12-31","value":-1491552900,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(28.45M)(33.94M)(26.70M)(18.23M)(14.92M)[{"date":"2020-12-31","value":-2845223200,"profit":false},{"date":"2021-12-31","value":-3393795600,"profit":false},{"date":"2022-12-31","value":-2670366200,"profit":false},{"date":"2023-12-31","value":-1823058800,"profit":false},{"date":"2024-12-31","value":-1491552900,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(31.80M)(35.29M)(23.61M)(17.90M)(14.20M)[{"date":"2020-12-31","value":-3179979300,"profit":false},{"date":"2021-12-31","value":-3528542900,"profit":false},{"date":"2022-12-31","value":-2360682800,"profit":false},{"date":"2023-12-31","value":-1790217900,"profit":false},{"date":"2024-12-31","value":-1420272400,"profit":false}]
EPS (Diluted)(169.34)(35.07)(29.20)(26.53)(15.32)[{"date":"2020-12-31","value":-16934.34,"profit":false},{"date":"2021-12-31","value":-3506.83,"profit":false},{"date":"2022-12-31","value":-2919.83,"profit":false},{"date":"2023-12-31","value":-2653.19,"profit":false},{"date":"2024-12-31","value":-1531.97,"profit":false}]

Quantum BioPharma Ltd. Ratios

Quantum BioPharma Ltd. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

QNTM
Cash Ratio 0.16
Current Ratio 1.41
Quick Ratio 1.39

Quantum BioPharma Ltd. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QNTM
ROA (LTM) -72.22%
ROE (LTM) -251.26%

Quantum BioPharma Ltd. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QNTM
Debt Ratio Lower is generally better. Negative is bad. 0.47
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.61

Quantum BioPharma Ltd. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QNTM
Trailing PE NM
Forward PE NM
P/S (TTM) 91.86
P/B 1.77
Price/FCF NM
EV/R 98.56
EV/Ebitda NM

FAQs

What is Quantum BioPharma Ltd. share price today?

Quantum BioPharma Ltd. (QNTM) share price today is $3.65

Can Indians buy Quantum BioPharma Ltd. shares?

Yes, Indians can buy shares of Quantum BioPharma Ltd. (QNTM) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNTM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Quantum BioPharma Ltd. be purchased?

Yes, you can purchase fractional shares of Quantum BioPharma Ltd. (QNTM) via the Vested app. You can start investing in Quantum BioPharma Ltd. (QNTM) with a minimum investment of $1.

How to invest in Quantum BioPharma Ltd. shares from India?

You can invest in shares of Quantum BioPharma Ltd. (QNTM) via Vested in three simple steps:

  • Click on Sign Up or Invest in QNTM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Quantum BioPharma Ltd. shares
What is Quantum BioPharma Ltd. 52-week high and low stock price?

The 52-week high price of Quantum BioPharma Ltd. (QNTM) is $38.25. The 52-week low price of Quantum BioPharma Ltd. (QNTM) is $3.75.

What is Quantum BioPharma Ltd. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Quantum BioPharma Ltd. (QNTM) is

What is Quantum BioPharma Ltd. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Quantum BioPharma Ltd. (QNTM) is 1.77

What is Quantum BioPharma Ltd. dividend yield?

The dividend yield of Quantum BioPharma Ltd. (QNTM) is 0.00%

What is the Market Cap of Quantum BioPharma Ltd.?

The market capitalization of Quantum BioPharma Ltd. (QNTM) is $14.80M

What is Quantum BioPharma Ltd.'s stock symbol?

The stock symbol (or ticker) of Quantum BioPharma Ltd. is QNTM

How Can Investors Use Quantum BioPharma Ltd. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Quantum BioPharma Ltd. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Quantum BioPharma Ltd. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Quantum BioPharma Ltd. shares for Indian investors?

When investing in Quantum BioPharma Ltd. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Quantum BioPharma Ltd. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Quantum BioPharma Ltd. share price with other stocks in the same sector?

Rather than merely checking the share price of Quantum BioPharma Ltd. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Quantum BioPharma Ltd. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top